Glioblastoma | KING
Indication: Glioblastoma
Title: KING: A Phase 2 Study Evaluating the Efficacy and Safety of selinexor (KPT-330) in Patients With Recurrent Gliomas
Drug: selinexor
| Phase I | Phase II | Phase III |
|---|---|---|
Phase I | Phase II | Phase III |
Indication: Glioblastoma
Title: KING: A Phase 2 Study Evaluating the Efficacy and Safety of selinexor (KPT-330) in Patients With Recurrent Gliomas
Drug: selinexor
| Phase I | Phase II | Phase III |
|---|---|---|
Phase I | Phase II | Phase III |